PEG-IFN alpha and ribavirin for HBV treatment

Details for Australian Patent Application No. 2006281498 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Popescu, Matei; Pluck, Nigel; Janssen, Henricus Leonardus Antonius

Agent Spruson & Ferguson

Pub. Number AU-A-2006281498

PCT Pub. Number WO2007/020195

Priority 05107473.0 15.08.05 EP

Filing date 3 August 2006

Wipo publication date 22 February 2007

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 31/7056 (2006.01)

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/020195 Priority application(s): WO2007/020195

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006281500-Device for treating snoring sounds, interruptions in breathing and obstructive sleep apnea

2006281497-Piperidine and piperazine derivatives as P2X3 antagonists